The histological effects of intracerebral injection or infusion of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and MPP+ (1-methyl-4-phenylpyridinium) in rat and mouse
- 30 September 1988
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 461 (2) , 361-366
- https://doi.org/10.1016/0006-8993(88)90268-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Histochemical localisation of monoamine oxidase A and B in rat brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neuronsEuropean Journal of Pharmacology, 1987
- Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to NeuromelaninScience, 1986
- MPTPNeurology, 1986
- 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayNature, 1986
- NORMAL MPTP BINDING IN PARKINSONIAN SUBSTANTIA NIGRA: EVIDENCE FOR EXTRANEURONAL TOXIN CONVERSION IN HUMAN BRAINThe Lancet, 1985
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the ratNeuropharmacology, 1982